Related Experiment Video
Updated: Oct 16, 2025

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
6.5K
SHORT-WAVELENGTH AUTOMATED PERIMETRY IN DIABETIC PATIENTS WITHOUT RETINOPATHY
Summary
Diabetic patients without retinopathy show impaired short-wavelength automated perimetry (SWAP) visual field function, indicating early neuroretinal changes. Diabetes duration and glycemic control did not significantly affect these visual field results.
Area of Science:
- Ophthalmology
- Diabetology
- Neuroscience
Background:
- Diabetes mellitus can lead to various ocular complications, including retinopathy.
- Early detection of retinal dysfunction in diabetic patients is crucial for timely intervention.
- Short-wavelength automated perimetry (SWAP) assesses specific retinal functions potentially affected early in disease progression.
Purpose of the Study:
- To compare SWAP results between diabetic patients without retinopathy and healthy controls.
- To determine if SWAP can detect retinal dysfunction before visible retinopathy develops.
- To investigate the influence of diabetes duration and glycemic control (HbA1c) on visual field indices.
Main Methods:
- 22 diabetic patients (Type 1 or 2) without retinopathy and 21 healthy controls underwent SWAP using the Humphrey Field Analyzer (SITA SWAP, 24-2 test).
- Visual field indices, including mean deviation (MD) and pattern standard deviation (PSD), were analyzed.
- Diabetes duration and HbA1c levels were recorded; statistical analyses included Mann-Whitney and Spearman correlation tests.
Main Results:
- Diabetic patients exhibited significantly lower MD (p < 0.05) and higher PSD (p < 0.05) compared to controls, indicating impaired visual field function.
- The average diabetes duration was 17 years with a mean HbA1c of 60.64 mmol/mol.
- A significant correlation was observed only between PSD and HbA1c (p > 0.05); diabetes duration showed no effect on visual field indices.
Conclusions:
- Retinal short-wavelength sensitivity appears compromised in diabetic patients even without clinically evident retinopathy.
- These findings suggest early neuroretinal impairment in diabetes.
- No association was found between visual field function and diabetes duration or glycemic control in this cohort.

